PAK5 and neoplasm: The NAL of the PAK7-MT group was also significantly higher than that of the PAK7-WT group in the TCGA cohort (7.52 vs. 4.30, P <0.001) (Figure 3C), indicating the enhanced tumor immunogenicity.